Mononucleosis Diagnostic Market Forecast, Trends by 2031
The mononucleosis diagnostic market size is projected to reach US$ 222.15 million by 2031 from US$ 151.44 million in 2023. The market is expected to register a CAGR of 4.9% during 2023–2031. Advancements in molecular diagnostics are likely to bring in new market trends during the forecast period.
Mononucleosis Diagnostic Market Analysis
As defined by the United Nations, the adolescent population (10–19 years of age) experiences a transition period from childhood to adulthood with significant growth and development. According to the United Nations Children's Fund (UNICEF), there are 1.3 billion adolescents in the world, making up 16% of the total population of the world. Mononucleosis, often referred to as "the kissing disease," primarily affects adolescents and young adults. The incidence of this disease is rising with the growing adolescent population. Epstein-Barr virus (EBV) is the most common cause of this disease, which often spreads through saliva while kissing or sharing drinks.
Healthcare providers experience a high demand for effective diagnostic tests to identify and confirm mononucleosis in adolescents. Monospot tests, EBV antibody tests, and throat cultures are the established diagnosis methods for this disease. The monospot test involves the detection of specific antibodies in the blood, while the EBV antibody test specifically focuses on detecting anti-EBV antibodies. Many healthcare providers are also focusing on offering point-of-care testing and telehealth services, which cater specifically to younger patients who prefer the convenience of quick, at-home diagnostics. These innovations ease the timely diagnoses, reducing barriers to access and increasing the overall testing rate. The ability to rapidly identify mononucleosis cases leads to better patient management and minimizes the disease's impact on academic and social life. Thus, the high risk of mononucleosis among adolescents results in a significant demand for diagnostic products and services.
Mononucleosis Diagnostic Market Overview
The mononucleosis diagnostic market is rapidly expanding due to the high risk among the adolescent population, and the rising health awareness and knowledge about the disease. Prominent players operating in the market are focusing on innovation and collaboration for enhanced product availability. Further, advancements in molecular diagnostics are expected to bring in new market trends in the coming years. However, the low accuracy of existing diagnostic tests hinders the mononucleosis diagnostic market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Mononucleosis Diagnostic Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Mononucleosis Diagnostic Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Mononucleosis Diagnostic Market Drivers and Opportunities
Rising Health Awareness and Knowledge About Mononucleosis Fuels Market Growth
Rising health awareness and knowledge regarding mononucleosis are the key factors driving the mononucleosis diagnostics market. As individuals become more informed about health issues, particularly unique infectious diseases such as mononucleosis, they tend to be more proactive in seeking diagnosis and treatment. With improved health literacy, individuals are better equipped to recognize the symptoms of mononucleosis, including extreme fatigue, fever, sore throat, and swollen lymph nodes. Early detection is also crucial for effective management, as it helps prevent complications and shortens the duration of the illness. Access to information through the Internet, social media, and educational campaigns enables patients to identify these symptoms with greater certainty. As a result, the raised awareness results in an upsurge in the demand for diagnostic tests.
The rise of social media and online health resources has fundamentally changed how individuals access information about health issues. Platforms such as Instagram, Twitter, and Facebook serve as channels for sharing personal experiences and expert insights related to mononucleosis. Influencers, health professionals, and organizations use these platforms to spread accurate information, demystify the condition, and combat misinformation. Consequently, people are becoming more educated about mononucleosis, leading to increased patient engagement in decision-making regarding the management, diagnosis, and treatment of the disease. The shift in mindset benefits patients and enhances the overall healthcare system by fostering proactive health management.
Rising health awareness also aligns with the broader trend of preventive care embraced by healthcare systems worldwide. The emphasis on prevention drives the demand for diagnostic tests for mononucleosis. Healthcare providers are responding by incorporating routine screenings and educational materials into their practices, further normalizing the process of seeking a diagnosis.
Development of Point-of-Care Testing to Create Lucrative Opportunities in Market
POC testing allows for rapid diagnosis at or near the site of patient care, enabling healthcare providers to make immediate clinical decisions and improve patient outcomes. Traditional laboratory tests often require hours or days to generate results, which can delay treatment and worsen symptoms. In contrast, POC tests can deliver results within minutes, facilitating timely intervention. The rapid turnaround is especially crucial for conditions such as mononucleosis, as early diagnosis can reduce complications and enhance patient comfort. POC testing can be implemented in various healthcare settings, including outpatient clinics, emergency departments, and home care settings. The accessibility is particularly beneficial in areas with limited laboratory infrastructure or in rural regions with insufficient healthcare resources. Bringing diagnostic capabilities closer to patients in the form of POC testing ensures that more individuals receive timely diagnoses and appropriate care, thereby broadening the reach of healthcare services. Moreover, this type of testing promotes greater engagement, as patients can receive their results quickly and discuss the next steps with their healthcare providers.
POC testing can be more cost-effective compared to traditional laboratory testing as they don't need extensive laboratory infrastructure, in turn lowering the overall costs for healthcare systems. The affordability of mononucleosis testing further drives its accessibility to a broader range of patients, especially in underserved populations. Recent advancements in biosensors and microfluidic technologies are driving the development of more sophisticated POC tests with improved sensitivity and specificity. These innovations ensure the reliability of POC tests in detecting mononucleosis. Market players offering POC test kits include SEKISUI Diagnostics (OSOM Mono Test), Abbott (Clearview Mono), and Cardinal Health [Cardinal Health MONO (Mononucleosis) II Rapid Test]. Thus, the development of POC testing generates substantial growth opportunities for the mononucleosis diagnostics market players.
Mononucleosis Diagnostic Market Report Segmentation Analysis
Key segments that contributed to the derivation of the mononucleosis diagnostic market analysis are type and end user.
- Based on type, the mononucleosis diagnostic market is segmented into Epstein Barr Virus antibody test, complete blood count test, and monospot test. The monospot test segment held the largest share of the market in 2023.
- In terms of end user, the mononucleosis diagnostic market is categorized into hospitals, laboratories, and others. The hospitals segment dominated the market in 2023.
Mononucleosis Diagnostic Market Share Analysis by Geography
The geographic scope of the mononucleosis diagnostic market report mainly focuses on five regions: North America, Asia Pacific, Europe, South & Central America, and the Middle East & Africa. In terms of revenue, North America dominated the market in 2023. It is estimated to dominate the global market during the forecast period. The US is the largest market for mononucleosis diagnostics in the world, and it is estimated to dominate the market during the forecast period as well. The market growth in the US is attributed to technological advancements, increased awareness, and a constant need for effective disease management strategies. According to the National Institutes of Health, the US records ~125,000 cases of infectious mononucleosis every year. Owing to such a high number, the awareness of the mononucleosis caused by the Epstein-Barr virus (EBV) is also on the rise in the country, which bolsters the demand for rapid and accurate diagnostic test kits, consumables, and services. Various testing methods adopted by healthcare providers in the country include serological tests based on antibody detection and molecular tests focused on viral DNA identification. The competitive landscape of the mononucleosis diagnostics market in the US is dominated by companies such as Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers. These companies invest in innovation and collaborations to enhance their product offerings and expand their market presence.
Mononucleosis Diagnostic Market Report Scope
Mononucleosis Diagnostic Market News and Recent Developments
The mononucleosis diagnostic market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. Below is a key development witnessed in the mononucleosis diagnostic market:
- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, along with SD Biosensor, Inc. and SJL Partners LLC, has announced the completion of their acquisition of Meridian. (Source: Meridian Bioscience, Inc. Website, January 2024)
Mononucleosis Diagnostic Market Report Coverage and Deliverables
The "Mononucleosis Diagnostic Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Mononucleosis diagnostic market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Mononucleosis diagnostic market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Mononucleosis diagnostic market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the mononucleosis diagnostic market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to register a CAGR of 4.9% during 2023–2031.
The mononucleosis diagnostic market value is expected to reach US$ 222.15 million by 2031.
Advancements in molecular diagnostics are likely to bring new growth trends in the market in the coming years.
Abbott Laboratories, Arlington Scientific Inc, Bio-Rad Laboratories Inc, Cardinal Health Inc, Meridian Bioscience Inc, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc, QuidelOrtho Corp, F. Hoffmann-La Roche Ltd, QIAGEN NV, Hologic Inc, bioMerieux SA, DiaSorin SpA, Immunostics Inc., Launch Diagnostics Ltd, Biorex Diagnostics, and ZEUS Scientific are among the key players operating in the market.
The high risk among the adolescent population, and the rising health awareness and knowledge about mononucleosis are among the most significant factors fueling the market growth.
North America dominated the market in 2023.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Mononucleosis Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Mononucleosis Diagnostics Market – Key Market Dynamics
5.1 Mononucleosis Diagnostics Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 High Risk among Adolescent Population
5.2.2 Rising Health Awareness and Knowledge About Mononucleosis
5.3 Market Restraints
5.3.1 Low Accuracy of Existing Diagnostic Tests
5.4 Market Opportunities
5.4.1 Development of Point-of-Care Testing
5.5 Future Trends
5.5.1 Advancements in Molecular Diagnostics
5.6 Impact of Drivers and Restraints:
6. Mononucleosis Diagnostics Market – Global Market Analysis
6.1 Mononucleosis Diagnostics Market Revenue (US$ Thousand), 2021–2031
6.2 Mononucleosis Diagnostics Market Forecast Analysis
7. Mononucleosis Diagnostics Market Analysis – by Type
7.1 Monospot Test
7.1.1 Overview
7.1.2 Monospot Test: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
7.2 Epstein Barr Virus Antibody Test
7.2.1 Overview
7.2.2 Epstein Barr Virus Antibody Test: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
7.3 Complete Blood Count Test
7.3.1 Overview
7.3.2 Complete Blood Count Test: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
8. Mononucleosis Diagnostics Market Analysis – by End User
8.1 Hospital
8.1.1 Overview
8.1.2 Hospital: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
8.2 Laboratories
8.2.1 Overview
8.2.2 Laboratories: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3 Others
8.3.1 Overview
8.3.2 Others: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9. Mononucleosis Diagnostics Market – Geographical Analysis
9.1 North America
9.1.1 North America Mononucleosis Diagnostics Market Overview
9.1.2 North America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1.3 North America: Mononucleosis Diagnostics Market Breakdown, by Type
9.1.3.1 North America: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Type
9.1.4 North America: Mononucleosis Diagnostics Market Breakdown, by End User
9.1.4.1 North America: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by End User
9.1.5 North America: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Country
9.1.5.1 United States: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1.5.1.1 United States: Mononucleosis Diagnostics Market Breakdown, by Type
9.1.5.1.2 United States: Mononucleosis Diagnostics Market Breakdown, by End User
9.1.5.2 Canada: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1.5.2.1 Canada: Mononucleosis Diagnostics Market Breakdown, by Type
9.1.5.2.2 Canada: Mononucleosis Diagnostics Market Breakdown, by End User
9.1.5.3 Mexico: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1.5.3.1 Mexico: Mononucleosis Diagnostics Market Breakdown, by Type
9.1.5.3.2 Mexico: Mononucleosis Diagnostics Market Breakdown, by End User
9.2 Europe
9.2.1 Europe Mononucleosis Diagnostics Market Overview
9.2.2 Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.2.1 Europe: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Type
9.2.2.2 Europe: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by End User
9.2.3 Europe: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Country
9.2.3.1 Germany: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.1.1 Germany: Mononucleosis Diagnostics Market Breakdown, by Type
9.2.3.1.2 Germany: Mononucleosis Diagnostics Market Breakdown, by End User
9.2.3.2 United Kingdom: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.2.1 United Kingdom: Mononucleosis Diagnostics Market Breakdown, by Type
9.2.3.2.2 United Kingdom: Mononucleosis Diagnostics Market Breakdown, by End User
9.2.3.3 France: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.3.1 France: Mononucleosis Diagnostics Market Breakdown, by Type
9.2.3.3.2 France: Mononucleosis Diagnostics Market Breakdown, by End User
9.2.3.4 Italy: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.4.1 Italy: Mononucleosis Diagnostics Market Breakdown, by Type
9.2.3.4.2 Italy: Mononucleosis Diagnostics Market Breakdown, by End User
9.2.3.5 Spain: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.5.1 Spain: Mononucleosis Diagnostics Market Breakdown, by Type
9.2.3.5.2 Spain: Mononucleosis Diagnostics Market Breakdown, by End User
9.2.3.6 Rest of Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.6.1 Rest of Europe: Mononucleosis Diagnostics Market Breakdown, by Type
9.2.3.6.2 Rest of Europe: Mononucleosis Diagnostics Market Breakdown, by End User
9.3 Asia Pacific
9.3.1 Asia Pacific Mononucleosis Diagnostics Market Overview
9.3.2 Asia Pacific: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.2.1 Asia Pacific: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Type
9.3.2.2 Asia Pacific: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by End User
9.3.3 Asia Pacific: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Country
9.3.3.1 China: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.1.1 China: Mononucleosis Diagnostics Market Breakdown, by Type
9.3.3.1.2 China: Mononucleosis Diagnostics Market Breakdown, by End User
9.3.3.2 Japan: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.2.1 Japan: Mononucleosis Diagnostics Market Breakdown, by Type
9.3.3.2.2 Japan: Mononucleosis Diagnostics Market Breakdown, by End User
9.3.3.3 India: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.3.1 India: Mononucleosis Diagnostics Market Breakdown, by Type
9.3.3.3.2 India: Mononucleosis Diagnostics Market Breakdown, by End User
9.3.3.4 Australia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.4.1 Australia: Mononucleosis Diagnostics Market Breakdown, by Type
9.3.3.4.2 Australia: Mononucleosis Diagnostics Market Breakdown, by End User
9.3.3.5 South Korea: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.5.1 South Korea: Mononucleosis Diagnostics Market Breakdown, by Type
9.3.3.5.2 South Korea: Mononucleosis Diagnostics Market Breakdown, by End User
9.3.3.6 Rest of APAC: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.6.1 Rest of APAC: Mononucleosis Diagnostics Market Breakdown, by Type
9.3.3.6.2 Rest of APAC: Mononucleosis Diagnostics Market Breakdown, by End User
9.4 South and Central America
9.4.1 South and Central America Mononucleosis Diagnostics Market Overview
9.4.2 South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.2.1 South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Type
9.4.2.2 South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by End User
9.4.3 South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Country
9.4.3.1 Brazil: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.3.1.1 Brazil: Mononucleosis Diagnostics Market Breakdown, by Type
9.4.3.1.2 Brazil: Mononucleosis Diagnostics Market Breakdown, by End User
9.4.3.2 Argentina: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.3.2.1 Argentina: Mononucleosis Diagnostics Market Breakdown, by Type
9.4.3.2.2 Argentina: Mononucleosis Diagnostics Market Breakdown, by End User
9.4.3.3 Rest of South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.3.3.1 Rest of South and Central America: Mononucleosis Diagnostics Market Breakdown, by Type
9.4.3.3.2 Rest of South and Central America: Mononucleosis Diagnostics Market Breakdown, by End User
9.5 Middle East and Africa
9.5.1 Middle East and Africa Mononucleosis Diagnostics Market Overview
9.5.2 Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.2.1 Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Type
9.5.2.2 Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by End User
9.5.3 Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Country
9.5.3.1 Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Country
9.5.3.2 Saudi Arabia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.3.2.1 Saudi Arabia: Mononucleosis Diagnostics Market Breakdown, by Type
9.5.3.2.2 Saudi Arabia: Mononucleosis Diagnostics Market Breakdown, by End User
9.5.3.3 South Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.3.3.1 South Africa: Mononucleosis Diagnostics Market Breakdown, by Type
9.5.3.3.2 South Africa: Mononucleosis Diagnostics Market Breakdown, by End User
9.5.3.4 United Arab Emirates: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.3.4.1 United Arab Emirates: Mononucleosis Diagnostics Market Breakdown, by Type
9.5.3.4.2 United Arab Emirates: Mononucleosis Diagnostics Market Breakdown, by End User
9.5.3.5 Rest of Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.3.5.1 Rest of Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by Type
9.5.3.5.2 Rest of Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by End User
10. Industry Landscape
10.1 Overview
10.2 Growth Strategies in Mononucleosis Diagnostic Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Abbott Laboratories
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Arlington Scientific Inc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Bio-Rad Laboratories Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Cardinal Health Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Meridian Bioscience Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Sekisui Diagnostics LLC
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Thermo Fisher Scientific Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 QuidelOrtho Corp
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 F. Hoffmann-La Roche Ltd
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 QIAGEN NV
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 Hologic Inc
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Products and Services
11.11.4 Financial Overview
11.11.5 SWOT Analysis
11.11.6 Key Developments
11.12 bioMerieux SA
11.12.1 Key Facts
11.12.2 Business Description
11.12.3 Products and Services
11.12.4 Financial Overview
11.12.5 SWOT Analysis
11.12.6 Key Developments
11.13 DiaSorin SpA
11.13.1 Key Facts
11.13.2 Business Description
11.13.3 Products and Services
11.13.4 Financial Overview
11.13.5 SWOT Analysis
11.13.6 Key Developments
11.14 Immunostics Inc.
11.14.1 Key Facts
11.14.2 Business Description
11.14.3 Products and Services
11.14.4 Financial Overview
11.14.5 SWOT Analysis
11.14.6 Key Developments
11.15 Launch Diagnostics Ltd
11.15.1 Key Facts
11.15.2 Business Description
11.15.3 Products and Services
11.15.4 Financial Overview
11.15.5 SWOT Analysis
11.15.6 Key Developments
11.16 Biorex Diagnostics
11.16.1 Key Facts
11.16.2 Business Description
11.16.3 Products and Services
11.16.4 Financial Overview
11.16.5 SWOT Analysis
11.16.6 Key Developments
11.17 ZEUS Scientific
11.17.1 Key Facts
11.17.2 Business Description
11.17.3 Products and Services
11.17.4 Financial Overview
11.17.5 SWOT Analysis
11.17.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of Terms for Mononucleosis Diagnostics Market
List of Tables
Table 1. Mononucleosis Diagnostics Market Segmentation
Table 2. North America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 3. North America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 4. United States: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 5. United States: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 6. Canada: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 7. Canada: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 8. Mexico: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 9. Mexico: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 10. Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 11. Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 12. Germany: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 13. Germany: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 14. United Kingdom: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 15. United Kingdom: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 16. France: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 17. France: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 18. Italy: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 19. Italy: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 20. Spain: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 21. Spain: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 22. Rest of Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 23. Rest of Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 24. Asia Pacific: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 25. Asia Pacific: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 26. China: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 27. China: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 28. Japan: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 29. Japan: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 30. India: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 31. India: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 32. Australia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 33. Australia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 34. South Korea: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 35. South Korea: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 36. Rest of APAC: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 37. Rest of APAC: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 38. South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 39. South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 40. Brazil: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 41. Brazil: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 42. Argentina: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 43. Argentina: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 44. Rest of South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 45. Rest of South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 46. Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 47. Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 48. Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Country
Table 49. Saudi Arabia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 50. Saudi Arabia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 51. South Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 52. South Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 53. United Arab Emirates: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 54. United Arab Emirates: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 55. Rest of Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 56. Rest of Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 57. Recent Organic Growth Strategies in Mononucleosis Diagnostic Market
Table 58. Recent Inorganic Growth Strategies in the Mononucleosis Diagnostic Market
Table 59. Glossary of Terms
List of Figures
Figure 1. Mononucleosis Diagnostics Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Mononucleosis Diagnostics Market Revenue (US$ Thousand), 2021–2031
Figure 5. Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 6. Mononucleosis Diagnostics Market Share (%) – by Type (2023 and 2031)
Figure 7. Monospot Test: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 8. Epstein Barr Virus Antibody Test: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 9. Complete Blood Count Test: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 10. Mononucleosis Diagnostics Market Share (%) – by End User (2023 and 2031)
Figure 11. Hospital: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 12. Laboratories: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 13. Others: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 14. North America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 15. North America: Mononucleosis Diagnostics Market Breakdown, by Type (2023 and 2031)
Figure 16. North America: Mononucleosis Diagnostics Market Breakdown, by End User (2023 and 2031)
Figure 17. North America: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 18. United States: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 19. Canada: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 20. Mexico: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 21. Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 22. Europe: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 23. Germany: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 24. United Kingdom: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 25. France: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 26. Italy: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 27. Spain: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 28. Rest of Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 29. Asia Pacific: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 30. Asia Pacific: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 31. China: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 32. Japan: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 33. India: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 34. Australia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 35. South Korea: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 36. Rest of APAC: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 37. South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 38. South and Central America: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 39. Brazil: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 40. Argentina: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 41. Rest of South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 42. Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 43. Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 44. Saudi Arabia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 45. South Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 46. United Arab Emirates: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 47. Rest of Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 48. Growth Strategies in Mononucleosis Diagnostic Market
The List of Companies - Mononucleosis Diagnostic Market
- Abbott Laboratories
- Arlington Scientific Inc
- Bio-Rad Laboratories Inc
- Cardinal Health Inc
- Meridian Bioscience Inc
- Sekisui Diagnostics LLC
- Thermo Fisher Scientific Inc
- QuidelOrtho Corp
- F. Hoffmann-La Roche Ltd
- QIAGEN NV
- Hologic Inc
- bioMerieux SA
- DiaSorin SpA
- Immunostics Inc.
- Launch Diagnostics Ltd
- Biorex Diagnostics
- ZEUS Scientific
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For